KRYS Jan 2025 190.000 call
- Insider Monkey
Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the quarter the fund returned 5.77% (net), compared to a 7.58% return for the Russell 2000 Growth Index. Despite a decline in many equity markets in […]
- Simply Wall St.
3 US Growth Companies With High Insider Ownership And Up To 96% Earnings Growth
Over the past year, the United States stock market has experienced a robust increase of 21%, though it remained flat in the last week. In this context, growth companies with high insider ownership can be particularly compelling as they often indicate confidence from those who know the company best, aligning well with forecasts of significant earnings growth.
- Investor's Business Daily
Krystal Biotech Stock Sees RS Rating Jump To 91
Krystal Biotech shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
